Home > PE Ratio > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
PE (Price/Earnings) Ratio

The Current P/E Ratio of ASTRAZENECA PHARMA INDIA is 194.57.

Share Price ₹6,375.5Dec 27,2024
Market Cap ₹15,938.6 Cr
Earnings-TTM₹81.9 CrTTM-Standalone Results
Price/Earnings194.57xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PE (Price/Earnings) ratio of ASTRAZENECA PHARMA INDIA

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of ASTRAZENECA PHARMA INDIA is calculated as :

Current Market Cap [ ₹15,938.6 Cr] as on Dec 27,2024

(/) Earnings [ ₹81.9 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 194.57x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for ASTRAZENECA PHARMA INDIA , the investors are currently willing to pay 194.57 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ASTRAZENECA PHARMA INDIA !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of ASTRAZENECA PHARMA INDIA over the last five years.

Historical PE (Price/Earnings) ratio chart of ASTRAZENECA PHARMA INDIA


PE Ratio Performance Analysis for ASTRAZENECA PHARMA INDIA

- ASTRAZENECA PHARMA INDIA 's latest p/e ratio is 194.57x.

- ASTRAZENECA PHARMA INDIA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 86.26x.

- ASTRAZENECA PHARMA INDIA 's operated at median p/e ratio of 82.35x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ASTRAZENECA PHARMA INDIA 's p/e ratio peaked in Mar2022 at 103.71x.

- ASTRAZENECA PHARMA INDIA 's p/e ratio hit its five-year low in Mar2021 of 80.66x.


How does ASTRAZENECA PHARMA INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
ASTRAZENECA PHARMA INDIA 81.92194.5715,938.6
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5040.11446,684.0
CIPLA LTD4,485.2227.12121,639.0
DR REDDYS LABORATORIES LTD5,406.8021.44115,931.0
ZYDUS LIFESCIENCES LTD4,298.9022.7797,876.4
DIVIS LABORATORIES LTD1,836.0084.93155,935.0
MANKIND PHARMA LTD2,124.8655.79118,539.0
TORRENT PHARMACEUTICALS LTD1,802.0063.97115,269.0
LUPIN LTD2,651.9438.33101,649.0
AUROBINDO PHARMA LTD3,598.8320.5073,785.0
ABBOTT INDIA LTD1,284.6648.4662,260.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ASTRAZENECA PHARMA INDIA 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 20.50x
Max industry PE 194.57x
Median industry PE 40.11x
Average industry PE 56.18x



You may also like the below Video Courses